Log in to save to my catalogue

Leukocytosis Associated With Medroxyprogesterone in Gender-Affirming and Fertility Treatments

Leukocytosis Associated With Medroxyprogesterone in Gender-Affirming and Fertility Treatments

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11890443

Leukocytosis Associated With Medroxyprogesterone in Gender-Affirming and Fertility Treatments

About this item

Full title

Leukocytosis Associated With Medroxyprogesterone in Gender-Affirming and Fertility Treatments

Publisher

United States: Cureus

Journal title

Curēus (Palo Alto, CA), 2025-02, Vol.17 (2), p.e78681

Language

English

Formats

Publication information

Publisher

United States: Cureus

More information

Scope and Contents

Contents

Leukocytosis, defined as an elevated white blood cell (WBC) count, can arise from physiological, infectious, neoplastic, or medication-related causes. While leukocytosis has been well-documented in conditions such as infections and malignancies, drug-induced leukocytosis is relatively rare, particularly in individuals undergoing gender transition t...

Alternative Titles

Full title

Leukocytosis Associated With Medroxyprogesterone in Gender-Affirming and Fertility Treatments

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11890443

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11890443

Other Identifiers

ISSN

2168-8184

E-ISSN

2168-8184

DOI

10.7759/cureus.78681

How to access this item